Records containing: Influenza
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2021-02-25Clinical Study of the Safety of Quadrivalent Live Attenuated Influenza Vaccine (LAIV4) in Children With Asthma of Varying Levels of Severity
-
CLINICAL_TRIALS study record update · 2021-02-21A Phase 1, Randomized, Controlled, Observer-blind Study to Assess the Reactogenicity, Safety, and Immunogenicity of a Live Attenuated Universal Influenza Vaccine (cH8/1N1 LAIV) Administered as a Single Priming Dose Followed Three Months Later by a Single Booster Dose of an Inactivated Universal Influenza Vaccine (cH5/1N1 IIV) (Adjuvanted With AS03A or Unadjuvanted) in 18 Through 39 Year-old Healthy Subjects, Contrasted With a Two Dose Schedule of an Inactivated Universal Influenza Vaccine (cH8/1N1 IIV + AS03A Followed Three Months Later by cH5/1N1 IIV + AS03A)
-
CLINICAL_TRIALS study record update · 2021-02-15Evaluation of the Immunogenicity, Safety, Reactogenicity, Efficacy, Effectiveness and Lot Consistency of FluBlok® Trivalent Recombinant Baculovirus-Expressed Hemagglutinin Influenza Vaccine in Healthy Adults Aged 18 to 49 Years
-
CLINICAL_TRIALS study record update · 2021-02-04Evaluation of Moderate to Severe Influenza Disease in Children 6 Months to 8 Years in Colorado
-
CLINICAL_TRIALS study record update · 2021-01-28A Single-center, Randomized, Double-blind, Placebo-controlled and Single-center, Randomized, Open, Double-crossed Food Impact Trial to Evaluate the Safety, Tolerability, Pharmacokineticof GP681 Tablets in Healthy Subjects
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2021-01-11A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of VAL-339851 in Healthy Subjects
-
CLINICAL_TRIALS study record update · 2020-12-19Safety and Efficacy of Endotracheal Intubation by Paramedics in Suspected/Confirmed COVID-19 Patients Under Cardiac Arrest Using Vie Scope Laryngoscope
-
CLINICAL_TRIALS study record update · 2020-12-17Collection of Serum Samples From Children 6 Months to < 9 Years of Age Who Received Fluzone® Quadrivalent and Adults ≥ 65 Years of Age Who Received Fluzone® High-Dose, Influenza Vaccines, 2019-2020 Formulations
-
CLINICAL_TRIALS study record update · 2020-12-17Infection Tracking in Travellers (ITIT)
-
CLINICAL_TRIALS study record update · 2020-12-17Reducing the Burden of Influenza After Solid-Organ Transplantation: the STOP-FLU Trial [Swiss Trial in Solid Organ Transplantation on Prevention of Influenza]
-
CLINICAL_TRIALS study record update · 2020-12-03Study of Antiviral Therapy of Influenza and ARVI With Kagocel ® in Children
-
CLINICAL_TRIALS study record update · 2020-12-01A Randomized Double-Blind, Placebo Controlled, Phase I Study of the Safety, Tolerability and Immunogenicity of a Live Attenuated H1N1 Vaccine in Healthy Individuals
-
CLINICAL_TRIALS study record update · 2020-11-30A Phase III, Randomized, Double-Blind Placebo-Controlled, Multicenter Study To Evaluate the Efficacy and Safety of Baloxavir Marboxil in Combination With Standard-of-Care Neuraminidase Inhibitor in Hospitalized Participants With Severe Influenza
-
CLINICAL_TRIALS study record update · 2020-11-16Double-blind Randomized Placebo-controlled Comparative Multicenter Study to Assess the Safety, Tolerability and Efficacy of XC221 in a Dose of 200mg Per Day in Patients With Uncomplicated Influenza or Other ARVI
-
CLINICAL_TRIALS study record update · 2020-11-12Kagocel for Oral Administration for the Prevention of Influenza and Other Acute Respiratory Viral Diseases in Young People
-
CLINICAL_TRIALS study record update · 2020-11-10Mucosal Correlates of Protection After Influenza Viral Challenge of Vaccinated and Unvaccinated Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2020-11-02Study of the Use of Kagocel® for the Prevention of ARVI and Influenza During the Epidemic Rise in the Incidence of Diseases in Adults
-
CLINICAL_TRIALS study record update · 2020-10-23Persistence of Influenza Vaccine-induced Antibody in Lung Transplant Patients and Healthy Individuals Beyond the Season
-
CLINICAL_TRIALS study record update · 2020-10-23Antibody Responses to Influenza Vaccine in Pre- and Post-lung Transplant Patients
-
CLINICAL_TRIALS study record update · 2020-10-23Effect of Annual Influenza Immunization on Antibody Response in Lung Transplant Patients
-
CLINICAL_TRIALS study record update · 2020-10-23Persistence of Influenza Vaccine-induced Antibodies in Lung Transplant Patients Between Seasons
-
CLINICAL_TRIALS study record update · 2020-10-23Lung Transplant Patients' T Cell Responses to Influenza Vaccine Viruses Between Seasons
-
CLINICAL_TRIALS study record update · 2020-10-23Influenza Vaccine Antibody Response and 6-month Persistence in Lung Transplant Recipients Using Two Definitions of Seroprotection
-
CLINICAL_TRIALS study record update · 2020-10-22An Open-Label Phase 3 Study to Assess the Immunogenicity and Safety of a Vero Cell-Derived Trivalent Seasonal Influenza Vaccine, Strain Composition 2010/2011, in an Adult and Elderly Population
-
CLINICAL_TRIALS study record update · 2020-10-22A Randomized Controlled Trial Comparing High-dose vs. Standard Influenza Vaccine in Adult Solid Organ Transplant Recipients